Nifedipine labeling illustrates the pediatric dilemma for off-patent drugs

Pediatrics. 2002 Feb;109(2):319-21. doi: 10.1542/peds.109.2.319.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Child
  • Drug Labeling / standards*
  • Humans
  • Nifedipine / therapeutic use*
  • Orphan Drug Production / legislation & jurisprudence
  • Patents as Topic / legislation & jurisprudence*
  • Pediatrics / legislation & jurisprudence*
  • Pediatrics / standards
  • United States
  • United States Food and Drug Administration

Substances

  • Nifedipine